Biologics segment dominatesmarket

Biologics segment dominates the market

10:52 AM, 23rd November 2017
Biologics segment dominates the market
Some of the key application segments of the global pharmaceutical continuous manufacturing technology market are biologics, dry powders, active pharmaceutical ingredients etc. (File photo)

Market Snapshot

In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This, in turn, serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption, according to a report by Transparency Market Research. 

Other advantages of pharmaceutical continuous manufacturing technology are the superior development speeds, higher process safety when employing hazardous chemistries, and the opportunity to perform reactions that cannot be run under batch processing. 

A study by Transparency Market Research forecasts the global pharmaceutical continuous manufacturing technology market to expand at a healthy CAGR of 8.8 percent from 2017 to 2025. Expanding at this pace, the market which was worth $1.74 bn in 2016 is expected to attain a value of $3.693 bn in 2025.

Contract Manufacturing Organizations in Asia Pacific to Drive Market

Some of the key application segments of the global pharmaceutical continuous manufacturing technology market are biologics, dry powders, active pharmaceutical ingredients etc. Of them, the segment of biologics accounts for a dominant position in the market. It held a share of about 35.3 percent in the global market in 2016. It was trailed by active pharmaceutical ingredient.

Application-wise, the global pharmaceutical continuous manufacturing technology market can be divided into contract manufacturing organizations, pharmaceutical companies etc. Currently, pharmaceutical companies lead the market with maximum demand and are trailed by contract manufacturing organizations. In the near future, the contract manufacturing organizations in Asia Pacific region are predicted to fuel market growth majorly. Along with increasing awareness about the technology, various initiatives by FDA are also egging manufacturers to shift to continuous manufacturing over batch manufacturing process.

Demand for Better Technology Propels Europe Market

From a geographical standpoint, currently Europe dominates the global pharmaceutical continuous manufacturing technology market. Strong demand for advanced technology from pharmaceutical companies and presence of many contract manufacturing entities has majorly fuelled the market in the region. The growth in Europe is primarily powered by the UK and Germany. The region’s leading share in 2016 came to around 35 percent. The market in the region is also expected to outshine others in terms of growth by registering a CAGR of 9.6 percent in the forecast period. Expanding at this pace, it is predicted to clock a revenue of $1.38 bn by 2025. This is mainly on account of the early availability of advanced technologies and greater number of technology providers across the region.

Asia Pacific trails Europe vis-a-vis market share. In 2016, the region held a share of about 34 percent in the global pharmaceutical continuous manufacturing market. The growth in Asia Pacific has been mainly driven by China and India, which are home to numerous contract manufacturing organizations. China is considered a highly promising market because of increasing acceptability of technologically advanced continuous manufacturing and growing awareness about the advantages of the technology.

North America comes in the third position in terms of market size. Initiatives by FDA to switch from current batch process to continuous manufacturing technology drives interest among the pharmaceutical companies.

Some of the prominent participants in the global pharmaceutical continuous manufacturing technology market are Siemens AG, GEA group, Continuus Pharmaceutical, S K Biotek ltd, Korsch AG, Scott Equipment Company, Corning Life Sciences and Chemtrix.

© Chemical Today Magazine

 

See the Write-Up in Chemical Today magazine

https://www.worldofchemicals.com/digitalissue/chemical-today-november-2017/25

View the magazine on Mobile, download the Chemical Today magazine app

http://bit.ly/21W5H0z

http://apple.co/1ZwID77

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Rising incidence of cancer to drive the market

Industry Insights The global high potency active pharmaceutical ingredients (APIs) market was valued at $14.4 billion in 2016 and is expected to grow ...

Read more
Putting GMP in place

By Debarati Das India boasts of being the third largest pharmaceutical industry in the world exporting pharma products to over 200 countries and aimi ...

Read more
Discovering new chemical equations

By Debarati Das Be it medicine, agriculture or addressing environmental issues, the chemical industry is constantly trying to find a better combinati ...

Read more
Finding a new way of drug development

In an interview, Uttam Tambar with Chemical Today Magazine talks about his research on streamlining the synthesis of pharmaceutical drugs by making in ...

Read more
The energy meter of a chemical plant

In an interview, V Gokuldas, managing director, HRS Process Systems Ltd with Chemical Today Magazine talks about the potential for thermal processing ...

Read more
Etching growth through innovation

In an interview, Ravi Doshi, Director (Marketing), Oswal Industries Limited with Chemical Today Magazine discusses at length about the valves industry ...

Read more